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Key Clinical Message
Salivary gland aplasia and hypoplasia are rarely described in the medical litera-
ture. This article presents a case of aplasia and hypoplasia of the major salivary
glands in a patient with Down syndrome. A literature review, as well as an
overview of the diagnosis and management of this condition, is presented.
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Introduction
Aplasia and hypoplasia of the major salivary glands are
rare developmental anomalies. They can be isolated or
part of a syndrome, as well as unilateral or bilateral. They
can affect more than one of the major glands [1, 2].
Salivary glands originate from the first branchial arches.
The parotid and the submandibular glands begin their
development at approximately 4–6 weeks of intrauterine
life, while the sublingual and minor glands form during
the 8th to 12th weeks of gestation [3]. Proliferation and
down-growth of the oral epithelium into the underlying
mesenchyme will form a network of epithelial cords
through branching morphogenesis. Lumina will subse-
quently form within these cords creating the excretory
pathways of the salivary glands. The inner epithelium at
the distal end of the branching cords will differentiate to
form secretory cells. These could be serous or mucous
depending on the developing gland. The peripheral
epithelium at the distal end of these cords will form the
myoepithelial cells. Contraction of these cells directs saliva
out of the acini into the ducts [3, 4].
The parotid glands produce almost exclusively serous
saliva and are most active during salivary flow stimula-
tion. Parotid secretion accounts for more than 50% of
stimulated saliva and only 28% of unstimulated saliva
[4]. The submandibular gland produces mixed saliva with
both mucous and serous components. The sublingual
gland represents the smallest of the major glands and it
produces purely mucous saliva. Together, the sub-
mandibular and sublingual glands produce 68% of the
unstimulated saliva. Minor salivary glands produce
mucous saliva in small proportions [5].
Saliva is crucial for maintaining oral homeostasis. Its
antimicrobial properties inhibit the establishment of a
pathologic flora while the buffering effect of bicarbonate
neutralizes the acid produced by cariogenic bacteria. Sal-
iva plays a role in the remineralization of teeth by bring-
ing calcium, phosphates, fluoride, and peptides to the
enamel surface. Its role in maintaining proper oral
hygiene is crucial as it allows for an auto-cleansing effect
and easier hygiene procedures. Lubrication provided by
serous saliva is essential for tasting, swallowing, and to
maintain oral comfort. Saliva plays a role in digestion
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through the production of salivary amylase and lipase
[3].
Down syndrome (DS) is a genetic disorder associated
with increasing maternal age with an overall incidence of
1/800 live births [6]. Characteristic oral and maxillofacial
features of patients affected by DS are presented in
Table 1. The underlying systemic disorders that affect
these patients can lead to a number of oral manifesta-
tions. For example, undiagnosed celiac disease can lead to
enamel defects and aphthous stomatitis [7], underlying
leukemia can lead to hemorrhagic gingival hyperplasia
and ulcerations [8, 9], and diabetes can cause severe peri-
odontitis [10]. Early detection and management of these
manifestations can improve quality of life and prognosis
of affected patients.
A recent study by Chaushu et al. suggests that salivary
flow is decreased in patients with DS even if there is a
clinical impression of sialorrhea [11]. Despite the fact that
xerogenic medications, age, and institutionalization had a
negative impact on flow rate, salivary output reduction
was well recognized as being an integral part of the syn-
drome [11]. In patients with DS, only a few cases of
hyposalivation caused by salivary gland underdevelopment
have been reported in the English medical literature. We
present a rare case of bilateral major salivary gland aplasia
and hypoplasia in a patient with DS presenting with sev-
ere oral dryness.
Case Study
A 23-year-old patient with DS was referred for
prosthodontic rehabilitation and for the correction of
poor aesthetics and severe loss of tooth substance affect-
ing the maxillary dentition. Review of systems revealed a
history of celiac disease, colitis, and hypothyroidism.
Clinical examination showed objective mucosal dryness, a
large fissured tongue, and severe erosion and attrition of
the maxillary dentition (Fig. 1). There was generalized
erythema and edema of the gingival tissues and oral
mucosae. Stensen’s duct openings could not be located
on buccal mucosae (Fig. 2), and no saliva could be
expressed upon palpation of the parotid and sub-
mandibular gland regions. A diagnosis of chronic erythe-
matous candidiasis was established and a congenital
absence of the parotid glands was strongly suspected.
Management included topical antifungal treatment, bian-
nual regular dental examinations, proper oral hydration,
use of an occlusal splint, and fluoride gel application in
custom trays 5 min before bedtime. Complete dental
rehabilitation was not recommended essentially due to
the poor long-term prognosis of the teeth.
Salivary gland ultrasonography was performed, and
upon cervicocephalic examination, both parotid glands
were undetected (Fig. 3A and B). The right submandibu-
lar gland measured 24 mm and the left measured less
than 18 mm. The submandibular glands were described
as hypoplastic considering that under normal circum-
stances, they measure on average 30 mm anterior-poster-
iorly (Fig. 4A and B) [12]. A diagnosis of salivary gland
aplasia and hypoplasia was rendered.
Table 1. Common maxillofacial signs of Down syndrome [8].
Facial Upslanting palpebral fissures, brachycephaly, epicanthal
folds, flattened nose bridge, flattened facies, muscle
hypotonia, protruding tongue, mouth breathing
Dental Hypodontia, hyperdontia, microdontia, taurodontism,
crown variants, delayed eruption
Periodontal Gingivitis, premature periodontitis and exfoliation of the
teeth
Mucosal Cheilitis, macroglossia, erythema and signs of infection
Skeletal Clefts, malocclusion, TMJ dysfunction
Figure 1. Severe erosion of the maxillary dentition.
Figure 2. Absence of Stensen’s duct orifice on the right
buccal mucosa. A similar appearance was noted on the left buccal
mucosa.
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Discussion
Very few cases of salivary gland aplasia and hypoplasia
have been reported in the literature. A review by Matsuda
et al. [13] states that the first case report of unilateral
submandibular aplasia was described by Gr€uber in 1885
following a cadaver dissection. From 1885 to 1999, Mat-
suda et al.’s review identified 44 cases of major salivary
gland aplasia of which 34 had bilateral aplasia. A familial
pattern was observed in six patients from three different
families.
A similar review carried out in 2010 by Chaushu et al.
[11] reported a total of 19 new cases from 1999 to 2010.
Among those, the authors compiled six cases of bilateral
aplasia of the parotid gland, six cases of bilateral aplasia
of the parotid and submandibular glands, and four cases
of bilateral aplasia of the submandibular gland. The
remaining three cases represented unilateral aplasia or sig-
nificant reduction in the salivary flow rate. Six of the 19
cases reported were associated with other developmental
anomalies such as lachrymal and ectodermal defects while
one case was associated with DS.
In 2010, N. Pham Dang et al.’s review article reported
34 cases of salivary gland aplasia since Gr€uber’s first
report in 1885 [2]. Some of the cases reported were men-
tioned in Matsuda’s review while others had been pub-
lished after 1999. Of the 34 cases, nine had bilateral
submandibular gland aplasia and only one reported bilat-
eral agenesis of the parotid. Thirteen patients in this
review presented congenital absence of unspecified major
salivary glands and had anomalies of the lacrimal puncta,
suggesting an association with Lacrimo-auriculo-dento-
digital (LADD) syndrome.
It is important to note that the three review articles did
not mention the inclusion and exclusion criteria nor the
key words used to perform the literature search. In addi-
tion, publications in which aplasia and hypoplasia of the
major salivary glands are a secondary focus were not
included.
Salivary gland aplasia and hypoplasia is not a recog-
nized manifestation of DS. For this reason, a limited
number of cases are reported in the English-language lit-
erature. In 2004, Ferguson et al. published a case of
Figure 3. Ultrasonography demonstrating the complete absence of
the left parotid gland in the presented case (A) compared to the
ultrasonography of a normal parotid gland in a healthy 16-year-old
male (B).
Figure 4. Ultrasonography demonstrating the hypoplastic left
submandibular gland in the presented case (A) compared to the
ultrasonography of the left submandibular gland in a healthy 16-year-
old male (B).
ª 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. 941
M. J. Chadi et al. Salivary gland aplasia in Down Syndrome
bilateral parotid aplasia in a 24-year-old patient with DS
[14]. The patient in this study had an overall good health
but presented important signs of hyposalivation. A bilat-
eral depression was observed in the periauricular area and
no Stensen’s duct orifices were located in the buccal
mucosae. A 99mTc-pertechnetate scan showed no uptake
in the parotid area as opposed to the submandibular
glands or thyroid regions.
A cross-sectional study published in 2013 by M. Odeh
compared the presence or the absence of major salivary
glands in 31 healthy children and 15 patients with DS
[15]. Using ultrasonography, it was reported that only
four patients with DS had aplasia of one or more salivary
gland compared to none in the control group. Three
other patients with DS showed hypoplasia of the parotids
and/or the submandibular glands, but one of those three
patients had severe facial burns and scarring, which could
have affected the size of his parotid gland. These results
suggest that there might be an association between sali-
vary gland aplasia/hypoplasia and DS. However, addi-
tional studies involving a larger number of patients have
to be conducted in order to further investigate this
possibility.
The initial diagnosis and the risk–benefit ratio are fac-
tors that determine the type of medical imaging ordered
in a given clinical situation. Ultrasonography is an opera-
tor-dependent method, which is widely used as a primary
step to detect calculi, cysts, tumors, and dimensional
changes of the salivary glands [16, 17]. It was selected in
this case because of its low cost, noninvasive nature,
absence of radiation, adequate sensitivity, and simplicity
in assessing the absence of the glands (Figs 3, 4A and B),
especially in the presence of a high clinical suspicion
index [18]. Magnetic resonance imaging (MRI) and com-
puted tomography (CT) scan can be used to detect such
anomalies. However, the cost of these imaging techniques
is high. MRI has the advantage of not exposing the
patient to ionizing radiation. It is useful to characterize
the tissue content and to obtain detailed information on
a lesion. However, it is a very expensive imaging modality
and the procedure itself can be troublesome to certain
patients [16]. CT scans expose patients to high doses of
radiation. However, they represent an essential imaging
modality and provide detailed information often needed
to diagnose and treat invasive and noninvasive lesions
[19]. Sialography is prescribed to highlight the ductal sys-
tem of a gland and to investigate ductal anomalies such
as a blockage [16].
Hyposalivation is defined as the clinical state of salivary
output reduction. This diagnosis is based on sialometric
test results. Dry mouth or xerostomia is a symptom.
These two concepts are closely related, yet they are rarely
simultaneously recorded [20, 21]. Before treating a patient
with dry mouth symptoms, it is essential to investigate
the underlying etiology and residual salivary gland activ-
ity. Management should be modulated depending on
these two factors.
One of the most important causes of xerostomia is the
long-term use of xerogenic drugs. A large number of
drugs, especially when combined, has been associated
with reduced salivary production [22]. Xerostomia is also
a major complication of radiation therapy to the head
and neck region [23]. Autoimmune diseases such as
Sj€ogren’s syndrome (SS) can cause oral dryness. Other
conditions such as diabetes, sarcoidosis, chronic graft-versus-
host disease, hepatitis, HIV, and chronic anxiety have
been reported to cause xerostomia [24]. As mentioned
earlier, salivary gland hypoplasia and aplasia are obvious
causes of oral dryness; however, they are rarely seen in
clinical practice.
Nape~nas et al. suggest a stepwise and multidisciplinary
approach to the treatment of xerostomia. Nonmedicinal
topical agents and lubricants are easily accessible tools
[17]. The use of a humidifier, increasing water intake,
and limiting diuretics or irritating foods should be sug-
gested [17]. If xerostomia is caused or aggravated by cer-
tain medications, the patient should consider another
treatment alternative with his physician. However, if the
outcome of these methods is not satisfying, a
patient–doctor discussion regarding expectations toward
treatment should follow, especially for patients with irre-
versibly damaged salivary glands [25].
Regular dental examinations should be scheduled at 4-
to 6-month intervals, and optimal oral hygiene should be
integrated in the patient’s daily routine [17, 21]. Low
sugar diets in conjunction with regular topical use of flu-
oride-based dental products are important approaches to
limit the incidence of decay. Custom trays can be fabri-
cated for daily fluoride application [21]. Pit and fissure
sealants can be used in selected cases. Candidiasis, a com-
mon complication of xerostomia, can be treated using
topical or systemic antifungals depending on the clinical
context [17].
Parasympathomimetic drugs such as pilocarpine and
cevimeline are generally reserved for patients with SS or
those treated with radiation to the head and neck. These
therapies have to be used cautiously because serious side
effects, interactions with other medications, and aggrava-
tion of existing medical conditions such as gastric ulcers,
uncontrolled asthma, and hypertension have been docu-
mented [17, 21].
Conclusion
To our knowledge, this is the fourth case report assessing
multiple gland hypoplasia and aplasia in patients with
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DS. This article highlights the importance of a dental
practitioner’s involvement in identifying and treating the
maxillofacial manifestations of a systemic disease or a
common syndrome. Further research with rigorous meth-
ods should be conducted in order to accurately determine
the prevalence of major salivary gland aplasia and hypo-
plasia in the general population and in patients with
Down syndrome.
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